In a previous study, TRIM2 was found to accelerate pancreatic cancer progression through the ROS-related NRF2/ITGB7/FAK axis [78], and excessive production of ROS has been considered to be the main mechanism of DMBA-mediated oral carcinogenesis [96]. Here, TRIM2 is linked to pancreatic neoplasm.